PURPOSE: Observational studies have shown that physical activity is inversely associated with breast cancer etiology. WISER is a randomized controlled trial examining the effects of exercise training on oxidative stress, and hormonal and metabolic factors associated with breast cancer risk. METHOD:Subjects were recruited via emails, flyers, and mass media advertising. Inclusion criteria included: sedentary, age 18-30 years, non-smokers, BMI 18-40 kg/m2, not using any hormonal contraceptives. After completion of all baseline measures subjects were randomized into a control group or an exercise intervention for 4 menstrual cycles. The exercise group was asked to complete five 45 min exercise sessions per week. Exercise intensity was set at 65-70% of maximum age- predicted heart rate (max HR) and increased every four weeks. All women provided blood samples four times during the study for measurement of blood F2-isoprostanes, hormones and IGF-axis proteins. In addition, 24-hour urine samples were collected at baseline and follow-up for measurement of estrogen metabolites, as well as 24-hour food records to monitor participants' diets. DISCUSSION: WISER consented 683 women among which 391 enrolled and 319 successfully completed the study. The overall dropout rate was 18.4% (n=72) with a higher number of participants dropping from the exercise group (n=46). No differences were found between dropouts and completers with respect to age, body weight, BMI, and demographic characteristics with the exception of degree of education. Findings from this trial will be useful in understanding the physiologic mechanisms by which exercise possibly contributes to decreased breast cancer risk. Published by Elsevier Inc.
RCT Entities:
PURPOSE: Observational studies have shown that physical activity is inversely associated with breast cancer etiology. WISER is a randomized controlled trial examining the effects of exercise training on oxidative stress, and hormonal and metabolic factors associated with breast cancer risk. METHOD: Subjects were recruited via emails, flyers, and mass media advertising. Inclusion criteria included: sedentary, age 18-30 years, non-smokers, BMI 18-40 kg/m2, not using any hormonal contraceptives. After completion of all baseline measures subjects were randomized into a control group or an exercise intervention for 4 menstrual cycles. The exercise group was asked to complete five 45 min exercise sessions per week. Exercise intensity was set at 65-70% of maximum age- predicted heart rate (max HR) and increased every four weeks. All women provided blood samples four times during the study for measurement of blood F2-isoprostanes, hormones and IGF-axis proteins. In addition, 24-hour urine samples were collected at baseline and follow-up for measurement of estrogen metabolites, as well as 24-hour food records to monitor participants' diets. DISCUSSION: WISER consented 683 women among which 391 enrolled and 319 successfully completed the study. The overall dropout rate was 18.4% (n=72) with a higher number of participants dropping from the exercise group (n=46). No differences were found between dropouts and completers with respect to age, body weight, BMI, and demographic characteristics with the exception of degree of education. Findings from this trial will be useful in understanding the physiologic mechanisms by which exercise possibly contributes to decreased breast cancer risk. Published by Elsevier Inc.
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: Anne McTiernan; Shelley S Tworoger; Cornelia M Ulrich; Yutaka Yasui; Melinda L Irwin; Kumar B Rajan; Bess Sorensen; Rebecca E Rudolph; Deborah Bowen; Frank Z Stanczyk; John D Potter; Robert S Schwartz Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: Evelyn M Monninkhof; Miranda J Velthuis; Petra H M Peeters; Jos W R Twisk; Albertine J Schuit Journal: J Clin Oncol Date: 2009-08-17 Impact factor: 44.544
Authors: A F Subar; F E Thompson; V Kipnis; D Midthune; P Hurwitz; S McNutt; A McIntosh; S Rosenfeld Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Rudolf Kaaks; Eva Lundin; Sabina Rinaldi; Jonas Manjer; Carine Biessy; Stefan Söderberg; Per Lenner; Lars Janzon; Elio Riboli; Göran Berglund; Göran Hallmans Journal: Cancer Causes Control Date: 2002-05 Impact factor: 2.506
Authors: Alma J Smith; William R Phipps; William Thomas; Kathryn H Schmitz; Mindy S Kurzer Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05 Impact factor: 4.254
Authors: Renate M Winkels; Kathleen M Sturgeon; Michael J Kallan; Lorraine T Dean; Zi Zhang; Margaret Evangelisti; Justin C Brown; David B Sarwer; Andrea B Troxel; Crystal Denlinger; Monica Laudermilk; Anna Fornash; Angela DeMichele; Lewis A Chodosh; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2017-07-21 Impact factor: 2.226
Authors: Andrea Y Arikawa; Maureen O'Dougherty; Beth C Kaufman; Kathryn H Schmitz; Mindy S Kurzer Journal: Contemp Clin Trials Date: 2011-11-27 Impact factor: 2.226
Authors: Andrea Y Arikawa; Holly E Jakits; Andrew Flood; William Thomas; Myron Gross; Kathryn H Schmitz; Mindy S Kurzer Journal: Nutr Res Date: 2014-10-16 Impact factor: 3.315
Authors: Andrea Y Arikawa; Mindy S Kurzer; William Thomas; Kathryn H Schmitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-09-10 Impact factor: 4.254
Authors: Talia N Crawford; Andrea Y Arikawa; Mindy S Kurzer; Kathryn H Schmitz; William R Phipps Journal: Fertil Steril Date: 2015-09-16 Impact factor: 7.329
Authors: Maureen O'Dougherty; Mary O Hearst; Andrea Y Arikawa; Steven D Stovitz; Mindy S Kurzer; Kathryn H Schmitz Journal: Transl Behav Med Date: 2012-06-01 Impact factor: 3.046
Authors: Ruth E Patterson; Graham A Colditz; Frank B Hu; Kathryn H Schmitz; Rexford S Ahima; Ross C Brownson; Kenneth R Carson; Jorge E Chavarro; Lewis A Chodosh; Sarah Gehlert; Jeff Gill; Karen Glanz; Debra Haire-Joshu; Karen Louise Herbst; Christine M Hoehner; Peter S Hovmand; Melinda L Irwin; Linda A Jacobs; Aimee S James; Lee W Jones; Jacqueline Kerr; Adam S Kibel; Irena B King; Jennifer A Ligibel; Jeffrey A Meyerhardt; Loki Natarajan; Marian L Neuhouser; Jerrold M Olefsky; Enola K Proctor; Susan Redline; Cheryl L Rock; Bernard Rosner; David B Sarwer; J Sanford Schwartz; Dorothy D Sears; Howard D Sesso; Meir J Stampfer; S V Subramanian; Elsie M Taveras; Julia Tchou; Beti Thompson; Andrea B Troxel; Marianne Wessling-Resnick; Kathleen Y Wolin; Mark D Thornquist Journal: Cancer Causes Control Date: 2013-02-03 Impact factor: 2.506
Authors: Andrea Y Arikawa; William Thomas; Sanjay R Patel; Mindy S Kurzer Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07-16 Impact factor: 4.254